Screener / SEC EDGAR /CIK 0001099800 /10-K filed Feb 25, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks

NYSE Health care · Medical Devices

Edwards Lifesciences EW

New risk paragraphs 11 Not in last year's 10-K Accounting checks 0 worth reading about, of 11 checks Insider buys 0 open-market, last 90 days Filings 6 in the last 30 days

Compare with peers Embed

Excel CSV Email alerts

Filings with the SEC since Apr 26, 2019

1,008 filings, 8 in the last 30 days

SEC filing index

Latest annual report Feb 25, 2026 10-K, period to Dec 31, 2025 Latest quarterly report Nov 4, 2026 10-Q, period to Sep 30, 2026 Latest current report Nov 4, 2026 8-K: Quarterly results

Filed in the last 30 days 8 of 1,008 in all

What the 8-Ks said

2 events in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.

CEO, CFO, COO or CAO: 2 (item 5.02)Auditor change: 0 (item 4.01)Not to be relied on: 0 (item 4.02)Cybersecurity: 0 (item 1.05)Restructuring: 0 (item 2.05)Listing notice: 0 (item 3.01)Impairment: 0 (item 2.06)Debt trigger: 0 (item 2.04)

May 4, 2026 CEO, CFO, COO or CAOCFO change “On May 4, 2026, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), announced that Theodora Mistras has been appointed as the Corporate Vice President, Chief Financial Officer of the Company, effective May 29, 2026, to succeed Scott B.” 8-K item 5.02 · all documents
Oct 30, 2025 CEO, CFO, COO or CAOCFO change “The Corporation is initiating a selection process to appoint a new Chief Financial Officer.” 8-K item 5.02 · all documents

From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.

Late filings, 8-K notices and going concern

None found in the last 2 years

All checks

Late filing notices (NT 10-K, NT 10-Q)

No notice in the last 2 years.
8-K notices: listing, impairment, debt trigger

No item 3.01, 2.06 or 2.04 in the last 2 years.
Going-concern language in the 10-K

No statement of substantial doubt in the latest 10-K.

Source: 10-K 0001099800-26-000009 (filed Feb 25, 2026): full text searched

Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.

Every filing on one line

Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)Planned insider sale (Form 144, 10b5-1)

20252026

All 71 events

Nov 10, 2026 Planned sale Lippis Daniel J. (Officer) gave notice of a planned sale of 1,857 shares worth about $194KForm 144, approximate sale date Nov 10, 2026, under a 10b5-1 plan adopted Feb 13, 2026
Nov 9, 2026 Planned sale BOBO DONALD E JR (Officer) gave notice of a planned sale of 48,900 shares worth about $5.0MForm 144, approximate sale date Nov 9, 2026, under a 10b5-1 plan adopted Feb 12, 2026
Nov 9, 2026 Planned sale Zovighian Bernard J (Officer, Director) gave notice of a planned sale of 46,200 shares worth about $4.8MForm 144, approximate sale date Nov 9, 2026, under a 10b5-1 plan adopted Jul 28, 2026
Nov 4, 2026 Planned sale Bernard J. Zovighian (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 145,696 shares, runs to May 14, 2027
Nov 4, 2026 8-K Quarterly results8-K item 2.02
Nov 4, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
Aug 31, 2026 Planned sale Dahl Andrew M. (Officer) gave notice of a planned sale of 544 shares worth about $50KForm 144, approximate sale date Aug 31, 2026
Aug 28, 2026 Planned sale Bruls Annette (Officer) gave notice of a planned sale of 2,644 shares worth about $238KForm 144, approximate sale date Aug 28, 2026
Aug 28, 2026 8-K Director or officer change8-K item 5.02
Aug 26, 2026 Planned sale Chopra Daveen (Officer) gave notice of a planned sale of 31,800 shares worth about $2.9MForm 144, approximate sale date Aug 26, 2026
Aug 26, 2026 Planned sale Markowitz Wayne (Officer) gave notice of a planned sale of 1,240 shares worth about $113KForm 144, approximate sale date Aug 26, 2026
Aug 11, 2026 Planned sale Lippis Daniel J. (Officer) gave notice of a planned sale of 1,857 shares worth about $171KForm 144, approximate sale date Aug 11, 2026, under a 10b5-1 plan adopted Feb 13, 2026
Aug 4, 2026 Planned sale Bernard J. Zovighian (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 145,696 shares, runs to May 14, 2027
Aug 4, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
Jul 30, 2026 Planned sale Markowitz Wayne (Officer) gave notice of a planned sale of 147 shares worth about $13KForm 144, approximate sale date Jul 30, 2026
Jul 30, 2026 Planned sale Ullem Scott B. (Former Affiliate) gave notice of a planned sale of 50,000 shares worth about $4.6MForm 144, approximate sale date Jul 30, 2026
Jul 28, 2026 Planned sale Markowitz Wayne (Officer) gave notice of a planned sale of 9,628 shares worth about $819KForm 144, approximate sale date Jul 28, 2026
Jul 27, 2026 Planned sale Zovighian Bernard J (Officer, Director) gave notice of a planned sale of 2,921 shares worth about $245KForm 144, approximate sale date Jul 27, 2026
Jul 23, 2026 8-K Quarterly results8-K item 2.02
May 29, 2026 Planned sale Dahl Andrew M. (Officer) gave notice of a planned sale of 568 shares worth about $49KForm 144, approximate sale date May 29, 2026
May 29, 2026 Planned sale Ullem Scott B. (Former Affiliate) gave notice of a planned sale of 64,152 shares worth about $5.6MForm 144, approximate sale date May 29, 2026
May 27, 2026 Planned sale BOBO JR FAMILY TRUST (Officer) gave notice of a planned sale of 23,145 shares worth about $2.0MForm 144, approximate sale date May 27, 2026
May 22, 2026 Planned sale Chopra Daveen (Officer) gave notice of a planned sale of 1,500 shares worth about $127KForm 144, approximate sale date May 22, 2026
May 18, 2026 Planned sale Lippis Daniel J. (Officer) gave notice of a planned sale of 1,858 shares worth about $151KForm 144, approximate sale date May 18, 2026, under a 10b5-1 plan adopted Feb 13, 2026
May 15, 2026 Planned sale BOBO DONALD E JR (Officer) gave notice of a planned sale of 9,968 shares worth about $818KForm 144, approximate sale date May 15, 2026
May 12, 2026 Planned sale Zovighian Bernard J (Officer, Director) gave notice of a planned sale of 36,874 shares worth about $2.9MForm 144, approximate sale date May 12, 2026, under a 10b5-1 plan adopted Dec 12, 2025
May 11, 2026 Planned sale Markowitz Wayne (Officer) gave notice of a planned sale of 593 shares worth about $47KForm 144, approximate sale date May 11, 2026
May 8, 2026 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
May 6, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
May 4, 2026 Planned sale Lippis Daniel J. (Officer) gave notice of a planned sale of 1,019 shares worth about $86KForm 144, approximate sale date May 4, 2026
May 4, 2026 Officer CFO changeOn May 4, 2026, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), announced that Theodora Mistras has been appointed as the Corporate Vice President, Chief Financial Officer of the Company, effective May 29, 2026, to succeed Scott B.
Apr 23, 2026 8-K Quarterly results8-K item 2.02
Mar 11, 2026 Planned sale Ullem Scott B. (Officer) gave notice of a planned sale of 26,000 shares worth about $2.2MForm 144, approximate sale date Mar 11, 2026, under a 10b5-1 plan adopted Jul 29, 2025
Mar 11, 2026 Planned sale Lippis Daniel J. (Officer) gave notice of a planned sale of 3,057 shares worth about $261KForm 144, approximate sale date Mar 11, 2026, under a 10b5-1 plan adopted Jul 30, 2025
Feb 26, 2026 Planned sale DONALD E BOBO JR. (Officer) gave notice of a planned sale of 24,000 shares worth about $2.0MForm 144, approximate sale date Feb 25, 2026
Feb 25, 2026 Planned sale Bernard J. Zovighian (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-K, up to 25,350 shares, runs to Jun 16, 2026
Feb 25, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
Feb 12, 2026 Planned sale Zovighian Bernard J (Officer, Director) gave notice of a planned sale of 22,430 shares worth about $1.7MForm 144, approximate sale date Feb 12, 2026
Feb 10, 2026 8-K Quarterly results8-K item 2.02
Jan 12, 2026 8-K Regulation FD disclosure8-K item 7.01
Jan 6, 2026 Planned sale BOBO DONALD E JR (Officer) gave notice of a planned sale of 45,360 shares worth about $3.9MForm 144, approximate sale date Jan 6, 2026, under a 10b5-1 plan adopted Feb 28, 2025
Dec 12, 2025 Planned sale BOBO DONALD E JR (Officer) gave notice of a planned sale of 5,487 shares worth about $460KForm 144, approximate sale date Dec 12, 2025
Dec 12, 2025 Planned sale STONE HEISZ LESLIE (Director) gave notice of a planned sale of 2,615 shares worth about $218KForm 144, approximate sale date Dec 12, 2025
Dec 12, 2025 Planned sale BOBO JR FAMILY TRUST (Officer) gave notice of a planned sale of 5,900 shares worth about $494KForm 144, approximate sale date Dec 12, 2025
Dec 11, 2025 Planned sale Chopra Daveen (Officer) gave notice of a planned sale of 2,000 shares worth about $169KForm 144, approximate sale date Dec 11, 2025
Dec 10, 2025 Planned sale Zovighian Bernard J (Officer, Director) gave notice of a planned sale of 3,863 shares worth about $322KForm 144, approximate sale date Dec 10, 2025, under a 10b5-1 plan adopted Feb 28, 2025
Dec 10, 2025 Planned sale BOBO DONALD E JR (Officer) gave notice of a planned sale of 11,340 shares worth about $951KForm 144, approximate sale date Dec 10, 2025, under a 10b5-1 plan adopted Feb 28, 2025
Dec 8, 2025 Planned sale Zovighian Bernard J (Officer, Director) gave notice of a planned sale of 21,487 shares worth about $1.8MForm 144, approximate sale date Dec 8, 2025, under a 10b5-1 plan adopted Feb 28, 2025
Dec 8, 2025 Planned sale Markowitz Wayne (Officer) gave notice of a planned sale of 583 shares worth about $50KForm 144, approximate sale date Dec 8, 2025
Nov 12, 2025 Planned sale Wood Larry L (Former Affiliate) gave notice of a planned sale of 26,850 shares worth about $2.3MForm 144, approximate sale date Nov 11, 2025, under a 10b5-1 plan adopted Feb 27, 2025
Nov 10, 2025 Planned sale Ullem Scott B. (Officer) gave notice of a planned sale of 20,700 shares worth about $1.7MForm 144, approximate sale date Nov 10, 2025, under a 10b5-1 plan adopted Jul 29, 2025
Nov 10, 2025 Planned sale Lippis Daniel J. (Officer) gave notice of a planned sale of 3,058 shares worth about $252KForm 144, approximate sale date Nov 10, 2025, under a 10b5-1 plan adopted Jul 30, 2025
Nov 5, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
Oct 30, 2025 Officer CFO changeThe Corporation is initiating a selection process to appoint a new Chief Financial Officer.
Oct 30, 2025 8-K Quarterly results8-K item 2.02
Aug 19, 2025 8-K Other events8-K item 8.01
Aug 6, 2025 Planned sale Scott B. Ullem (Corporate Vice President, Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 59,700 shares, runs to Apr 9, 2026
Aug 6, 2025 Planned sale Daniel J. Lippis (Corporate Vice President) adopted a 10b5-1 trading planreported in the 10-Q, up to 7,134 shares, runs to May 1, 2026
Aug 6, 2025 8-K Regulation FD disclosure8-K item 7.01
Aug 6, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
Jul 25, 2025 8-K Director or officer change8-K item 5.02
Jul 24, 2025 8-K Quarterly results8-K item 2.02
May 8, 2025 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
May 6, 2025 Planned sale Donald E. Bobo, Jr. (Corporate Vice President, Strategy & Corporate Development) adopted a 10b5-1 trading planreported in the 10-Q, up to 66,650 shares, runs to Apr 16, 2026
May 6, 2025 Planned sale Larry L. Wood (Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement (TAVR) and Surgical Structural Heart) adopted a 10b5-1 trading planreported in the 10-Q, up to 53,700 shares, runs to Apr 16, 2026
May 6, 2025 Planned sale Bernard J. Zovighian (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 62,833 shares, runs to Feb 9, 2026
May 6, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
Apr 23, 2025 8-K Quarterly results8-K item 2.02
Feb 28, 2025 Planned sale Bernard J. Zovighian (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-K, up to 14,925 shares, runs to May 16, 2025
Feb 28, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
Feb 11, 2025 8-K Quarterly results8-K item 2.02

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind · each form links to sec.gov

Filed	Form	What it is	Period
Nov 10, 2026	144	Notice of planned insider sale		all files
Nov 10, 2026	4	Insider trade	Nov 10, 2026	all files
Nov 9, 2026	144	Notice of planned insider sale		all files
Nov 9, 2026	144	Notice of planned insider sale		all files
Nov 9, 2026	4	Insider trade	Nov 9, 2026	all files
Nov 9, 2026	4	Insider trade	Nov 9, 2026	all files
Nov 4, 2026	10-Q	Quarterly report	Sep 30, 2026	all files · tables
Nov 4, 2026	8-K	Quarterly results	Nov 4, 2026	all files
Oct 8, 2026	4	Insider trade	Oct 8, 2026	all files
Sep 14, 2026	4	Insider trade	Sep 11, 2026	all files
Sep 14, 2026	4	Insider trade	Sep 13, 2026	all files
Sep 11, 2026	4	Insider trade	Sep 11, 2026	all files
Sep 11, 2026	4	Insider trade	Sep 11, 2026	all files
Aug 31, 2026	144	Notice of planned insider sale		all files
Aug 31, 2026	4	Insider trade	Aug 31, 2026	all files
Aug 28, 2026	144	Notice of planned insider sale		all files
Aug 28, 2026	4	Insider trade	Aug 28, 2026	all files
Aug 28, 2026	8-K	Director or officer change	Aug 25, 2026	all files
Aug 26, 2026	144	Notice of planned insider sale		all files
Aug 26, 2026	144	Notice of planned insider sale		all files
Aug 26, 2026	4	Insider trade	Aug 26, 2026	all files
Aug 26, 2026	4	Insider trade	Aug 26, 2026	all files
Aug 11, 2026	144	Notice of planned insider sale		all files
Aug 11, 2026	4	Insider trade	Aug 11, 2026	all files
Aug 4, 2026	S-8	Shares registered for employee plans		all files
Aug 4, 2026	10-Q	Quarterly report	Jun 30, 2026	all files · tables
Jul 30, 2026	144	Notice of planned insider sale		all files
Jul 30, 2026	144	Notice of planned insider sale		all files
Jul 30, 2026	4	Insider trade	Jul 30, 2026	all files
Jul 28, 2026	144	Notice of planned insider sale		all files
Jul 28, 2026	4	Insider trade	Jul 28, 2026	all files
Jul 27, 2026	144	Notice of planned insider sale		all files
Jul 27, 2026	4	Insider trade	Jul 27, 2026	all files
Jul 23, 2026	8-K	Quarterly results	Jul 23, 2026	all files
Jul 13, 2026	4	Insider trade	Jul 11, 2026	all files
Jul 10, 2026	4	Insider trade	Jul 9, 2026	all files
Jul 10, 2026	4	Insider trade	Jul 10, 2026	all files
Jul 7, 2026	4	Insider trade	Jul 7, 2026	all files
Jun 30, 2026	4	Insider trade	Jun 30, 2026	all files
Jun 17, 2026	4	Insider trade	Jun 17, 2026	all files
Jun 12, 2026	11-K	Employee plan annual report	Dec 31, 2025	all files
Jun 12, 2026	11-K	Employee plan annual report	Dec 31, 2025	all files
Jun 1, 2026	3	New insider	May 29, 2026	all files
May 29, 2026	144	Notice of planned insider sale		all files
May 29, 2026	144	Notice of planned insider sale		all files
May 29, 2026	4	Insider trade	May 29, 2026	all files
May 27, 2026	144	Notice of planned insider sale		all files
May 27, 2026	4	Insider trade	May 27, 2026	all files
May 27, 2026	SD	Conflict minerals report		all files
May 22, 2026	144	Notice of planned insider sale		all files
May 22, 2026	4	Insider trade	May 22, 2026	all files
May 18, 2026	144	Notice of planned insider sale		all files
May 18, 2026	4	Insider trade	May 18, 2026	all files
May 18, 2026	4	Insider trade	May 15, 2026	all files
May 15, 2026	144	Notice of planned insider sale		all files
May 12, 2026	144	Notice of planned insider sale		all files
May 12, 2026	4	Insider trade	May 11, 2026	all files
May 12, 2026	4	Insider trade	May 11, 2026	all files
May 12, 2026	4	Insider trade	May 11, 2026	all files
May 11, 2026	144	Notice of planned insider sale		all files
May 11, 2026	4	Insider trade	May 11, 2026	all files
May 11, 2026	4	Insider trade	May 7, 2026	all files
May 11, 2026	4	Insider trade	May 7, 2026	all files
May 11, 2026	4	Insider trade	May 11, 2026	all files
May 8, 2026	4	Insider trade	May 8, 2026	all files
May 8, 2026	4	Insider trade	May 8, 2026	all files
May 8, 2026	4	Insider trade	May 8, 2026	all files
May 8, 2026	4	Insider trade	May 8, 2026	all files
May 8, 2026	4	Insider trade	May 8, 2026	all files
May 8, 2026	4	Insider trade	May 8, 2026	all files
May 8, 2026	4	Insider trade	May 8, 2026	all files
May 8, 2026	4	Insider trade	May 7, 2026	all files
May 8, 2026	4	Insider trade	May 7, 2026	all files
May 8, 2026	4	Insider trade	May 8, 2026	all files
May 8, 2026	4	Insider trade	May 7, 2026	all files
May 8, 2026	4	Insider trade	May 7, 2026	all files
May 8, 2026	4	Insider trade	May 7, 2026	all files
May 8, 2026	4	Insider trade	May 7, 2026	all files
May 8, 2026	8-K	Director or officer change, Shareholder vote results	May 7, 2026	all files
May 6, 2026	10-Q	Quarterly report	Mar 31, 2026	all files · tables
May 5, 2026	4	Insider trade	May 3, 2026	all files
May 5, 2026	4	Insider trade	May 3, 2026	all files
May 4, 2026	144	Notice of planned insider sale		all files
May 4, 2026	4	Insider trade	May 1, 2026	all files
May 4, 2026	4	Insider trade	May 3, 2026	all files
May 4, 2026	4	Insider trade	May 3, 2026	all files
May 4, 2026	8-K	Director or officer change, Regulation FD disclosure	May 2, 2026	all files
Apr 29, 2026	SCHEDULE 13G	5%+ owner (passive)		all files
Apr 23, 2026	8-K	Quarterly results	Apr 23, 2026	all files
Apr 9, 2026	4	Insider trade	Apr 9, 2026	all files
Apr 6, 2026	4	Insider trade	Apr 6, 2026	all files
Apr 2, 2026	4	Insider trade	Apr 2, 2026	all files
Mar 26, 2026	DEFA14A	Extra proxy material		all files
Mar 26, 2026	ARS	Annual report to shareholders	Dec 31, 2025	all files
Mar 26, 2026	DEFA14A	Extra proxy material		all files
Mar 26, 2026	DEF 14A	Proxy statement	May 7, 2026	all files
Mar 26, 2026	SCHEDULE 13G/A	5%+ owner (passive), amended		all files
Mar 11, 2026	144	Notice of planned insider sale		all files
Mar 11, 2026	144	Notice of planned insider sale		all files
Mar 11, 2026	4	Insider trade	Mar 11, 2026	all files

Show the other 75 filings on this page

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Sources

SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.

Also

Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/EW/export.csv") into a cell.

Next:Earnings releases